fundvisualizer.com

Templeton Growth CFTGQX

Performance (before sales charge)

As of 09/30/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 09/30/2024
Stock
54.87%
Non-U.S. Stock
41.31%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
3.82%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 09/30/2024

Basic materials

2.33%

Consumer cyclical

11.54%

Financial services

15.44%

Real estate

0.00%

Consumer defensive

5.84%

Health care

14.50%

Utilities

2.85%

Communication services

4.05%

Energy

5.24%

Industrials

15.59%

Technology

18.79%

Top 10 holdings

As of 09/30/2024

AstraZeneca PLC
3.62%
UnitedHealth Group Inc
3.25%
Rolls-Royce Holdings PLC
3.19%
Taiwan Semiconductor Manufacturing Co Ltd ADR
3.11%
Microsoft Corp
3.01%
PNC Financial Services Group Inc
2.98%
Alphabet Inc Class A
2.89%
TJX Companies Inc
2.88%
Unilever PLC
2.86%
Bank of America Corp
2.73%
Fund assets

$8.77 Billion

Share class

C

Morningstar category

Global Large-Stock Blend

Expense ratio

1.79%

Investment objective

World Stock

Documents